Choose your area of enquiry

Home
Recruiting Trials

Recruiting Trials

Research Area

Study Name

Basic Eligibility

Doctors Referral

Participant Enquiry

Cardiology

Research Area:

Cardiology

Stenosis

Study Name:

DynamX Bioadaptor

Basic Eligibility:

Aged 20 or older, myocardial ischemia, able to undergo PTCA, stenting and CABG

Doctors Referral:

Refer a Patient

Participant Enquiry:

Trial for eligible patients at Middlemore Hospital.

Research Area:

Cardiology

Acute Coronary Syndrome

Study Name:

AEGIS-II (CSL112_3001)

Basic Eligibility:

Type 1 Myocardial infarction
Have at least two coronary artery territories of disease > 50%
Be on treatment for Diabetes

Doctors Referral:

Refer a Patient

Participant Enquiry:

Trial for eligible patients currently an inpatient at Middlemore Hospital.

Gastroenterology/Hepatology

Research Area:

Gastroenterology/Hepatology

Non-alcoholic Steatohepatitis

Study Name:

MK-3655-001-00 (NASH)

Basic Eligibility:

Male or postmenopausal female, aged 18-80 years old, diagnosed Nonalcoholic Steatohepatitis, no other chronic liver disease

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Research Area:

Gastroenterology/Hepatology

Non-alcoholic Fatty Liver Disease

Study Name:

MK-6024 NAFLD

Basic Eligibility:

Aged between 18-70 years old
Diagnosis of Non-alcoholic Fatty Liver Disease
Have a BMI between 25 to 50 kg/m2

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Research Area:

Gastroenterology/Hepatology

Ulcerative colitis

Study Name:

AVOGADRO-UC (Ulcerative colitis)

Basic Eligibility:

Age less than 65 years, have diagnosed ulcerative colitis and experiencing increase in daily stool frequency and/or rectal bleeding, no allergy to antibiotic vancomycin, willing to undergo two colonoscopy procedures as part of the study (3 months apart)

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Research Area:

Gastroenterology/Hepatology

Chronic Hepatitis B

Study Name:

BRII-179-835-001, DCR-HBVS-101, GS-US-493-5342, VIR (VIR-2218)

Basic Eligibility:

Aged 18 to 65
Chronic Hepatitis B infection
On stable NUC treatment (e.g Entecavir orTenofovir)

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Haematology

Research Area:

Haematology

Multiple Myeloma

Study Name:

BGB-11417-105

Basic Eligibility:

Age ≥ 18
Diagnosed with Relapsed or Refractory Multiple Myeloma
No long-term use of Prednisone

Doctors Referral:

Refer a Patient

Participant Enquiry:

Ask your Haematologist if this is right for you.

Research Area:

Haematology

Multiple Myeloma

Study Name:

FRAIL-M

Basic Eligibility:

Age ≥ 18
Newly diagnosed multiple myeloma
Ineligible for autologous stem cell transplant
No prior treatment for multiple myeloma except localised radiotherapy or a short course of steroids

Doctors Referral:

Refer a Patient

Participant Enquiry:

Ask your Haematologist if this is right for you.

Research Area:

Haematology

Myelodysplastic Syndrome (MDS)

Study Name:

KER050 (Anemia in MDS)

Basic Eligibility:

Age ≥ 18
Diagnosed with Myelodysplastic Syndrome (MDS)
Anemia

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Research Area:

Haematology

Multiple Myeloma

Study Name:

DREAMM8

Basic Eligibility:

Age ≥ 18
Diagnosed with Relapsed or Refractory Multiple Myeloma.

Doctors Referral:

Refer a Patient

Participant Enquiry:

Ask your Haematologist if this is right for you.

Research Area:

Haematology

Essential Thrombocythemia

Study Name:

IMG-7289-CTP-201

Basic Eligibility:

Age ≥ 18
Diagnosis of Essential Thrombocythemia
Failure of standard therapy, e.g. Hydroxyurea

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Infectious Diseases

Research Area:

Infectious Diseases

Viral Respiratory Disease

Study Name:

SHIVERS

Basic Eligibility:

Viral respiratory disease
Acute presentation to Middlemore Emergency Department or Intensive care unit

Doctors Referral:

Refer a Patient

Participant Enquiry:

Trial for eligible patients with acute presentation at Middlemore Hospital.

Research Area:

Infectious Diseases

Rheumatic Fever

Study Name:

Start

Basic Eligibility:

Aged between 5 - 14 years
Newly diagnosed with Acute rheumatic fever

Doctors Referral:

Refer a Patient

Participant Enquiry:

Trial for eligible patients currently an inpatient at Middlemore Hospital.

Research Area:

Infectious Diseases

Respiratory Syncytial Virus

Study Name:

RSV study

Basic Eligibility:

Healthy woman aged between 18 and 49 years of age
Pregnant with no known increased risk for complications
Singleton pregnancy

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Research Area:

Infectious Diseases

Staph Aureus infection

Study Name:

Staph Aureus Vaccine

Basic Eligibility:

Are 18-50 years of age.
Have a current/recent skin infection.
No ongoing illness or history of serious chronic/progressive disease.

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Plastics and Burns

Research Area:

Plastics and Burns

Wound healing

Study Name:

NPWT

Basic Eligibility:

≥ 18 years of age, undergoing a surgical procedure resulting in a closed approximately linear incision

Doctors Referral:

Refer a Patient

Participant Enquiry:

Trial for eligible patients at Middlemore Hospital.

Renal

Research Area:

Renal

Hypertension

Study Name:

Polypill

Basic Eligibility:

Aged 18 years or older, hypertensive, no more than 3 current blood-pressure lowering medications.

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Research Area:

Renal

IgA Neuropathy

Study Name:

The Align Study

Basic Eligibility:

Aged 18 or older, diagnosis of IgAN, on a stable dose of an ACE inhibitor or ARB / unable to tolerate this therapy.

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Respiratory

Research Area:

Respiratory

Bronchiectasis

Study Name:

ASPEN

Basic Eligibility:

Aged 18-85, diagnosed non-cystic fibrosis bronchiectasis, two or more exacerbations in the past 12 months.

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Research Area:

Respiratory

Chronic obstructive pulmonary disease

Study Name:

PACE

Basic Eligibility:

Aged between 40 and 85 years
Diagnosed with COPD
A history of cardiovascular disease, including heart failure, ischaemic heart disease, tachyarrhythmias, and hypertension

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Research Area:

Respiratory

Bronchiectasis

Study Name:

Resveratrol

Basic Eligibility:

Aged over 18 years
Confirmed diagnosis of bronchiectasis within 5 years
Pulmonary exacerbation requiring antibiotics in the past 12 months

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Rheumatology

Research Area:

Rheumatology

Ankylosing Spondylitis/Axial Spondyloarthritis

Study Name:

Ankylosing Spondylitis/Axial Spondyloarthritis

Basic Eligibility:

Aged 18 years or older
Diagnosis of Ankylosing Spondylitis or Axial Spondyloarthritis

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Research Area:

Rheumatology

Polymyalgia Rheumatica

Study Name:

HUBBLE PMR

Basic Eligibility:

Aged between 50-80.
Have been diagnosed with Polymyalgia Rheumatica (PMR).
Have experienced improvement in PMR symptoms with Prednisone.

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Research Area:

Rheumatology

Giant Cell Arthritis

Study Name:

Select - GCA (M16-852)

Basic Eligibility:

Age 50 or over
Diagnosed Giant Cell Arthritis
Headache, jaw pain, vision loss
Shoulder and/or hip pain

Doctors Referral:

Refer a Patient

Participant Enquiry:

See if you qualify

Spinal Unit

Research Area:

Spinal Unit

Wound healing

Study Name:

FPH Spinal

Basic Eligibility:

Aged 22 and older, undergoing 1 or 2 level spinal decompression

Doctors Referral:

Refer a Patient

Participant Enquiry:

Trial for eligible patients at Middlemore Hospital.

Participant Navigation

About Us

Middlemore Clinical Trials is a fully integrated research unit based at Middlemore Hospital in the heart of South Auckland, New Zealand.

We perform biopharma and medical device clinical trials in partnership with all hospital departments focusing on the diseases and Long term health conditions that affect our diverse community.

Our Contacts

Phone: +64 9 270 9758
Email: info@mmclintrials.nz